Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
NCT01517529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2015-11-20
Summary
The major goal of this project is to identify the role of the immune responses in the emergence of protease inhibitor mutants during therapy.
Conditions
- Hepatitis C
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of Cincinnati
lead OTHER
Principal Investigators
-
Mohamed Tarek. M Shata, MD, PhD · University of Cincinnati
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2014-07-31
- Completion
- 2014-12-31
Countries
- United States
Study Locations
More Related Trials
-
Prospective Studies on Immunopathogenesis of Liver Fibrosis
NCT04943978 ·Status: RECRUITING
-
Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders
NCT00001351 ·Status: ENROLLING_BY_INVITATION
-
Study of New Biological Markers for Prediction of Severe Acute Pancreatitis
NCT00786591 ·Status: COMPLETED
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED
-
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
NCT05669677 ·Status: COMPLETED
-
Dose Effect Relationship of MTX and IBD
NCT03531593 ·Status: COMPLETED
-
Identification and Verification of Neutrophil Extracellular Trap Net Related Markers in Acute-on-chronic Liver Failure
NCT05909319 ·Status: UNKNOWN
-
A Study on Factors of Biochemical Response in Autoimmune Hepatitis
NCT06356506 ·Status: NOT_YET_RECRUITING
-
S100A8/A9 and Innate Immunity in Liver Disease
NCT05793983 ·Status: UNKNOWN
-
Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis
NCT03740685 ·Status: UNKNOWN
-
Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
NCT00867243 ·Status: TERMINATED
-
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy
NCT00606528 ·Status: COMPLETED
-
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
NCT06470997 ·Status: RECRUITING
-
Study IL- 35 Level and Fibronectin Type Ⅲ Domain Containing Protein 5 \ Irsin (FNDC5 rs3480) Gene Variations in Chronic Hepatitis B.
NCT06023745 ·Status: UNKNOWN
-
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease
NCT00610597 ·Status: COMPLETED
-
Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
NCT06691529 ·Status: NOT_YET_RECRUITING
-
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
NCT01644903 ·Status: RECRUITING
-
Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients
NCT06865859 ·Status: RECRUITING
-
Hepatitis C in Clinically Discordant Hemophilic Siblings
NCT00007371 ·Status: COMPLETED
-
Hepatitis C Virus in Neutrophil Granulocyte Progenitor Cells
NCT02545387 ·Status: WITHDRAWN
-
Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic Patients
NCT03965260 ·Status: COMPLETED
-
A Study of the Intestinal Microbiome in Patients with Cirrhosis
NCT06808698 ·Status: NOT_YET_RECRUITING
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis
NCT04195724 ·Status: UNKNOWN ·Phase: NA
-
Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.
NCT00213707 ·Status: UNKNOWN